Terrance Mayes, of the Stanford Cancer Institute, was named chair of the NCCN DEI Directors Forum, and Loretta Erhunmwunsee, of City of Hope National Medical Center, was named vice-chair.
The National Comprehensive Cancer Network updated its chronic myeloid leukemia treatment guidelines, recommending Scemblix (asciminib) for the treatment of adults with newly diagnosed Ph+ CML-CP as a category 1-preferred.
